Position in TEVA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$40,580,210
+$1,406,018 QoQ
Shares Held
1,197,763
-7.9% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#77
of 675 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AVIVA PLC holds $99,862,653 across 5 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (40.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
1,197,763 | $40,580,210 | |
| 2 | ZTS |
Zoetis Inc.
|
389,051 | $27,957,204 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
32,903 | $17,827,832 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
77,269 | $13,022,917 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
4,277 | $474,490 |
All Filings in TEVA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,580,210 | 1,197,763 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $39,174,192 | 1,300,604 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $34,595,099 | 1,108,462 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $22,695,770 | 1,123,553 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||